Skip to content
GPCR Therapeutics logo — New hope for cancer patients

GPCR Therapeutics

New hope for cancer patients

Founded 2013 Korea South Korea South 18 employees Venture round Biotechnology, Health and Wellness +1

General Information

Company Name GPCR Therapeutics
Founded Year 2013
Location Korea South Korea South
Employees 18
Industries Biotechnology, Health and Wellness, Pharmaceutical
Funding Stage Venture round
Social

BounceWatch is an independent company data service, not affiliated with GPCR Therapeutics. To contact GPCR Therapeutics, visit gpcr.co.kr.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does GPCR Therapeutics compare?

A PDF of GPCR Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting GPCR Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About GPCR Therapeutics

GPCR Therapeutics is a venture-backed, clinical stage international biopharmaceutical company with a focus on developing therapeutics leveraging its proprietary GPCR data. The company has identified over 1000 GPCR pairs for drug screening campaigns, aiming to develop personalized combination therapies targeting specific disease indications and patient subpopulations. GPCR Therapeutics' innovative approach targets the unique pharmacology of GPCR pairs to develop life-changing treatments for cancer and other diseases. Established in 2013 and headquartered in South Korea, GPCR Therapeutics operates within the Biotechnology, Health and Wellness, and Pharmaceutical industries. Despite not having publicly disclosed its latest investment round or the involved investors, the company's slogan, "New hope for cancer patients," encapsulates its mission and potential contribution to the healthcare sector. Overall, GPCR Therapeutics demonstrates promising prospects in the biopharmaceutical space, leveraging its proprietary data-driven approach to potentially revolutionize cancer treatment and address unmet medical needs in other disease areas.

No funding data available for GPCR Therapeutics yet.

GPCR Therapeutics Alternatives & Competitors

View All Alternatives
GPCR Therapeutics vs

#biopharma #biotech #drugdiscovery #GPCR #Immunooncology #immunosuppression

Grant
88 employees
Biotechnology, Health Care
GPCR Therapeutics vs

Targeting neurodegeneration with novel science and treatments so patients can THINK, AGAIN

Grant
20 employees
Biotechnology, Health and Wellness
GPCR Therapeutics vs

Boundless GPCR drug discovery

Seed
3 employees
Biotechnology, Health Care

FAQ About GPCR Therapeutics

New hope for cancer patients
GPCR Therapeutics was founded in 2013.
GPCR Therapeutics is headquartered in Korea South.
GPCR Therapeutics operates in Biotechnology, Health and Wellness and Pharmaceutical.
GPCR Therapeutics has approximately 18 employees.
Top alternatives and competitors to GPCR Therapeutics include Domain Therapeutics, CuraSen Therapeutics, Inc., Design Pharmaceuticals Inc., Mosaic TX, Repertoire Immune Medicines. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
GPCR Therapeutics and Domain Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for GPCR Therapeutics, https://bouncewatch.com/company/gpcr-therapeutics, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout